Albemarle Co. ( NYSE:ALB – Get Free Report ) has received a consensus rating of “Hold” from the twenty-three analysts that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, fifteen have given a hold recommendation and seven have issued a buy recommendation on the company.
The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $117.10. A number of research analysts recently commented on the stock.
HSBC downgraded shares of Albemarle from a “buy” rating to a “hold” rating and set a $95.00 price objective on the stock. in a research report on Wednesday, July 17th.
Hsbc Global Res raised shares of Albemarle to a “hold” rating in a research note on Wednesday, July 17th. JPMorgan Chase & Co. cut their price objective on Albemarle from $115.
00 to $78.00 and set a “neutral” rating for the company in a report on Monday, August 19th. Oppenheimer lowered their target price on Albemarle from $188.
00 to $178.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 9th. Finally, Deutsche Bank Aktiengesellschaft cut their price target on Albemarle from $105.
00 to $80.00 and set a “hold” rating for the company in a research note on Friday, August 16th. View Our Latest Research Report on ALB Institutional Trading of Albemarle Albemarle Price Performance ALB opened at $87.
44 on Monday. Albemarle has a 12-month low of $71.97 and a 12-month high of $188.
47. The company has a quick ratio of 1.75, a current ratio of 2.
67 and a debt-to-equity ratio of 0.38. The firm has a market capitalization of $10.
28 billion, a P/E ratio of 31.80, a PEG ratio of 8.03 and a beta of 1.
54. The stock has a fifty day moving average of $87.73 and a 200-day moving average of $108.
05. Albemarle ( NYSE:ALB – Get Free Report ) last announced its quarterly earnings data on Wednesday, July 31st. The specialty chemicals company reported $0.
04 EPS for the quarter, missing analysts’ consensus estimates of $0.53 by ($0.49).
The business had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.34 billion.
Albemarle had a positive return on equity of 6.38% and a negative net margin of 6.72%.
The company’s revenue was down 39.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $7.
33 earnings per share. Equities analysts forecast that Albemarle will post 0.69 EPS for the current fiscal year.
Albemarle Increases Dividend The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 1st. Stockholders of record on Friday, September 13th will be paid a $0.405 dividend.
The ex-dividend date of this dividend is Friday, September 13th. This is a positive change from Albemarle’s previous quarterly dividend of $0.40.
This represents a $1.62 dividend on an annualized basis and a dividend yield of 1.85%.
Albemarle’s payout ratio is presently 58.91%. Albemarle Company Profile ( Get Free Report Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide.
It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. Read More Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.
com's FREE daily email newsletter ..
Business
Albemarle Co. (NYSE:ALB) Given Average Recommendation of “Hold” by Analysts
Albemarle Co. (NYSE:ALB – Get Free Report) has received a consensus rating of “Hold” from the twenty-three analysts that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, fifteen have given a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month price [...]